Anesthesiology and Pain Medicine

Published by: Kowsar

Comparing the Effects of 5% Albumin and 6% Hydroxyethyl Starch 130/0.4 (Voluven) on Renal Function as Priming Solutions for Cardiopulmonary Bypass: A Randomized Double Blind Clinical Trial

Mahmood Hosseinzadeh Maleki 1 , Pooya Derakhshan 2 , * , Amir Rahmanian Sharifabad 1 and Ahmad Amouzeshi 1
Authors Information
1 Atherosclerosis and Coronary Artery Research Center, Birjand University of Medical Sciences, Birjand, Iran
2 Department of Anesthesiology, Rasoul Akram Hospital, Iran University of Medical Sciences, Tehran, Iran
Article information
  • Anesthesiology and Pain Medicine: February 01, 2016, 6 (1); e30326
  • Published Online: January 18, 2016
  • Article Type: Research Article
  • Received: May 29, 2015
  • Revised: July 26, 2015
  • Accepted: August 17, 2015
  • DOI: 10.5812/aapm.30326

To Cite: Hosseinzadeh Maleki M, Derakhshan P, Rahmanian Sharifabad A, Amouzeshi A. Comparing the Effects of 5% Albumin and 6% Hydroxyethyl Starch 130/0.4 (Voluven) on Renal Function as Priming Solutions for Cardiopulmonary Bypass: A Randomized Double Blind Clinical Trial, Anesth Pain Med. 2016 ; 6(1):e30326. doi: 10.5812/aapm.30326.

Copyright © 2016, Iranian Society of Regional Anesthesia and Pain Medicine (ISRAPM). This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License ( which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
1. Background
2. Objectives
3. Patients and Methods
4. Results
5. Discussion
  • 1. Choi YS, Shim JK, Hong SW, Kim JC, Kwak YL. Comparing the effects of 5% albumin and 6% hydroxyethyl starch 130/0.4 on coagulation and inflammatory response when used as priming solutions for cardiopulmonary bypass. Minerva Anestesiol. 2010; 76(8): 584-91[PubMed]
  • 2. Himpe D. Colloids versus crystalloids as priming solutions for cardiopulmonary bypass: a meta-analysis of prospective, randomised clinical trials. Acta Anaesthesiol Belg. 2003; 54(3): 207-15[PubMed]
  • 3. Langeron O, Doelberg M, Ang E, Bonnet F, Capdevila X, Coriat P. Voluven??, a Lower Substituted Novel Hydroxyethyl Starch (HES 130/0.4), Causes Fewer Effects on Coagulation in Major Orthopedic Surgery than HES 200/0.5. Anesth Analg. 2001; : 855-62[DOI]
  • 4. Gallandat Huet RC, Siemons AW, Baus D, van Rooyen-Butijn WT, Haagenaars JA, van Oeveren W, et al. A novel hydroxyethyl starch (Voluven) for effective perioperative plasma volume substitution in cardiac surgery. Can J Anaesth. 2000; 47(12): 1207-15[PubMed]
  • 5. Arellano R, Gan BS, Salpeter MJ, Yeo E, McCluskey S, Pinto R, et al. A triple-blinded randomized trial comparing the hemostatic effects of large-dose 10% hydroxyethyl starch 264/0.45 versus 5% albumin during major reconstructive surgery. Anesth Analg. 2005; 100(6): 1846-53[DOI][PubMed]
  • 6. Baldassarre S, Vincent JL. Coagulopathy induced by hydroxyethyl starch. Anesth Analg. 1997; 84(2): 451-3[PubMed]
  • 7. Cope JT, Banks D, Mauney MC, Lucktong T, Shockey KS, Kron IL, et al. Intraoperative hetastarch infusion impairs hemostasis after cardiac operations. Ann Thorac Surg. 1997; 63(1): 78-82[PubMed]
  • 8. Payani N, Foroughi M, Dabbagh A. The Effect of Intravenous Administration of Active Recombinant Factor VII on Postoperative Bleeding in Cardiac Valve Reoperations; A Randomized Clinical Trial. Anesth Pain Med. 2015; 5(1)[DOI][PubMed]
  • 9. Knutson JE, Deering JA, Hall FW, Nuttall GA, Schroeder DR, White RD, et al. Does Intraoperative Hetastarch Administration Increase Blood Loss and Transfusion Requirements After Cardiac Surgery? Anesth Analg. 2000; 9(4): 801-7[DOI]
  • 10. Navickis RJ, Haynes GR, Wilkes MM. Effect of hydroxyethyl starch on bleeding after cardiopulmonary bypass: a meta-analysis of randomized trials. J Thorac Cardiovasc Surg. 2012; 144(1): 223-30[DOI][PubMed]
  • 11. Niemi TT, Suojaranta-Ylinen RT, Kukkonen SI, Kuitunen AH. Gelatin and hydroxyethyl starch, but not albumin, impair hemostasis after cardiac surgery. Anesth Analg. 2006; 102(4): 998-1006[DOI][PubMed]
  • 12. Onorati F, Santarpino G, Renzulli A, De Feo M, De Santo LS, Della Corte A, et al. Does priming implementation with low-dose albumin reduce postoperative bleeding following cardiopulmonary bypass? Int J Artif Organs. 2003; 26(3): 211-6[PubMed]
  • 13. Tigchelaar I, Huet RCG, Boonstra PW, van Oeveren W. Comparison of three plasma expanders used as priming fluids in cardiopulmonary bypass patients. Perfusion. 1998; 13(5): 297-303[DOI]
  • 14. Vanhoonacker J, Ongenae M, Vanoverschelde H, Donadoni R. Hydroxyethyl starch 130/0.4 versus modified fluid gelatin for cardiopulmonary bypass priming: the effects on postoperative bleeding and volume expansion needs after elective CABG. Acta Anaesthesiol Belg. 2009; 60(2): 91-7[PubMed]
  • 15. Wiesen P, Canivet JL, Ledoux D, Roediger L, Damas P. Effect of hydroxyethylstarch on renal function in cardiac surgery: a large scale retrospective study. Acta Anaesthesiol Belg. 2005; 56(3): 257-63[PubMed]
  • 16. Frenette AJ, Bouchard J, Bernier P, Charbonneau A, Nguyen LT, Rioux JP, et al. Albumin administration is associated with acute kidney injury in cardiac surgery: a propensity score analysis. Crit Care. 2014; 18(6): 602[DOI][PubMed]
  • 17. Kumar AB, Suneja M. Cardiopulmonary bypass-associated acute kidney injury. Anesthesiology. 2011; 114(4): 964-70[DOI][PubMed]
  • 18. Joudi M, Fathi M, Soltani G, Izanloo A. Factors affecting on serum lactate after cardiac surgery. Anesth Pain Med. 2014; 4(4)[DOI][PubMed]
  • 19. Wilkes MM, Navickis RJ. Patient survival after human albumin administration. A meta-analysis of randomized, controlled trials. Ann Intern Med. 2001; 135(3): 149-64[PubMed]
  • 20. Bellomo R, Auriemma S, Fabbri A, D'Onofrio A, Katz N, McCullough PA, et al. The pathophysiology of cardiac surgery-associated acute kidney injury (CSA-AKI). Int J Artif Organs. 2008; 31(2): 166-78[PubMed]
  • 21. Tiryakioglu O, Yildiz G, Vural H, Goncu T, Ozyazicioglu A, Yavuz S. Hydroxyethyl starch versus Ringer solution in cardiopulmonary bypass prime solutions (a randomized controlled trial). J Cardiothorac Surg. 2008; 3: 45[DOI][PubMed]
  • 22. Sakpal TV. Sample size estimation in clinical trial. Perspect Clin Res. 2010; 1(2): 67-9[PubMed]
  • 23. Kuitunen AH, Hynynen MJ, Vahtera E, Salmenpera MT. Hydroxyethyl starch as a priming solution for cardiopulmonary bypass impairs hemostasis after cardiac surgery. Anesth Analg. 2004; 98(2): 291-7[PubMed]
  • 24. Brinkman AC, Romijn JW, van Barneveld LJ, Greuters S, Veerhoek D, Vonk AB, et al. Profound effects of cardiopulmonary bypass priming solutions on the fibrin part of clot formation: an ex vivo evaluation using rotation thromboelastometry. J Cardiothorac Vasc Anesth. 2010; 24(3): 422-6[DOI][PubMed]
  • 25. Wilkes MM, Navickis RJ, Sibbald WJ. Albumin versus hydroxyethyl starch in cardiopulmonary bypass surgery: a meta-analysis of postoperative bleeding. Ann Thorac Surg. 2001; 72(2): 527-33[PubMed]
  • 26. Skhirtladze K, Base EM, Lassnigg A, Kaider A, Linke S, Dworschak M, et al. Comparison of the effects of albumin 5%, hydroxyethyl starch 130/0.4 6%, and Ringer's lactate on blood loss and coagulation after cardiac surgery. Br J Anaesth. 2014; 112(2): 255-64[DOI][PubMed]
  • 27. Tigchelaar I, Gallandat Huet RC, Korsten J, Boonstra PW, van Oeveren W. Hemostatic effects of three colloid plasma substitutes for priming solution in cardiopulmonary bypass. Eur J Cardiothorac Surg. 1997; 11(4): 626-32[PubMed]
  • 28. Van Der Linden P, James M, Mythen M, Weiskopf RB. Safety of modern starches used during surgery. Anesth Analg. 2013; 116(1): 35-48[DOI][PubMed]
  • 29. Warren BB, Durieux ME. Hydroxyethyl starch: safe or not. Anesth Analg. 1997; 84(1): 206-12
  • 30. Weiskopf RB. Equivalent efficacy of hydroxyethyl starch 130/0.4 and human serum albumin: if nothing is the same, is everything different? The importance of context in clinical trials and statistics. Anesthesiology. 2013; 119(6): 1249-54[DOI][PubMed]
  • 31. de Jonge E, Levi M. Effects of different plasma substitutes on blood coagulation: a comparative review. Crit Care Med. 2001; 29(6): 1261-7[PubMed]
  • 32. Van der Linden P, De Ville A, Hofer A, Heschl M, Gombotz H. Six percent hydroxyethyl starch 130/0.4 (Voluven(R)) versus 5% human serum albumin for volume replacement therapy during elective open-heart surgery in pediatric patients. Anesthesiology. 2013; 119(6): 1296-309[DOI][PubMed]
Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:



Create Citiation Alert
via Google Reader

Readers' Comments